Rett syndrome is a neurodevelopmental disorder and an important cause of mental retardation and autistic behavior in girls and in a small group of boys. In 1999, mutation of the methyl-CpG binding protein 2 (MECP2) gene encoding a transcriptional repressor on the X chromosome was found to cause Rett syndrome. Since this discovery, significant research has focused on the elucidation of its specific role in the central nervous system. Recent studies revealed that MECP2 is expressed in more differentiated neurons rather than in less differentiated neuroblasts and that MECP2 is involved in the maturation and maintenance of neurons, including dendritic arborization and axonal projections, rather than in early cell fate decisions in the mammalian brain. In this review, we summarize recent findings regarding regional, temporal, and cell type—specific MECP2 expression in the central nervous system; neurobiologic abnormalities in MECP2 -mutant mice; and MECP2 target genes in the central nervous system. (J Child Neurol 2005;20:753—759).
Get full access to this article
View all access options for this article.
References
1.
Armstrong DD : Neuropathology of Rett syndrome. Ment Retard Dev Disabil Res Rev2002;8:72—76.
2.
Glaze DG: Neurophysiology of Rett syndrome. Ment Retard Dev Disabil Res Rev2002;8:66—71.
3.
Hagberg B.: Clinical manifestations and stages of Rett syndrome. Ment Retard Dev Disabil Res Rev2002;8:61—65.
4.
Kriaucionis S., Bird A.: DNA methylation and Rett syndrome. Hum Mol Genet2003;12(Suppl 2):R221—R227.
5.
Shahbazian MD , Zoghbi HY: Rett syndrome and MECP2: Linking epigenetics and neuronal function. Am J Hum Genet2002 ;71: 1259—1272.
6.
Percy AK, Lane JB: Rett syndrome: Clinical and molecular update. Curr Opin Pediatr2004; 16:670-677.
7.
Moog U., Smeets EE, van Roozendaal KE, et al: Neurodevelopmental disorders in males related to the gene causing Rett syndrome in females (MECP2). Eur J PaediatrNeurol2003;7:5—12.
8.
Amir RE, Van den Veyver IB, Wan M., et al: Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet1999 ;23:185—188.
9.
Lewis JD, Meehan RR, Henzel WJ, et al: Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA. Cell1992;69:905—914.
10.
Nan X., Campoy FJ, Bird A.: MECP2 is a transcriptional repressor with abundant binding sites in genomic chromatin. Cell1997;88:471—481.
11.
Chen RZ, Akbarian S., Tudor M., et al: Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice. Nat Genet2001;27:327—331.
12.
Guy J., Hendrich B., Holmes M., et al: A mouse MECP2-null mutation causes neurological symptoms that mimic Rett syndrome. Nat Genet2001;27:322—326.
13.
Shahbazian M., Young J., Yuva-Paylor L., et al: Mice with truncated MECP2 recapitulate many Rett syndrome features and display hyperacetylation of histone H3. Neuron2002;35:243—254.
14.
Moretti P., Bouwknecht JA, Teague R., et al: Abnormalities of social interactions and home-cage behavior in a mouse model of Rett syndrome. Hum Mol Genet2005;14:205—220.
15.
Shahbazian MD, Antalffy B., Armstrong DL, et al: Insight into Rett syndrome: MECP2 levels display tissue- and cell-specific differences and correlate with neuronal maturation. Hum Mol Genet2002;11:115—124.
16.
Reichwald K. , Thiesen J., Wiehe T., et al: Comparative sequence analysis of the MECP2-locus in human and mouse reveals new transcribed regions. Mamm Genome2000;11:182—190.
17.
Lai EC: MicroRNAs: Runts of the genome assert themselves. Curr Biol2003;13:R925—R936.
18.
Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell2004;116:281—297.
19.
Kriaucionis S., Bird A.: The major form of MECP2 has a novel N-terminus generated by alternative splicing. Nucleic Acids Res2004;32:1818—1823.
20.
Mnatzakanian GN, Lohi H., Munteanu I., et al: A previously unidentified MECP2 open reading frame defines a new protein isoform relevant to Rett syndrome. Nat Genet2004;36:339—341.
21.
Luikenhuis S., Giacometti E., Beard CF, et al: Expression of MECP2 in postmitotic neurons rescues Rett syndrome in mice. Proc Natl Acad Sci U S A2004; 101:6033-6038.
22.
Collins AL, Levenson JM, Vilaythong AP, et al: Mild overexpression of MECP2 causes a progressive neurological disorder in mice. Hum Mol Genet2004;13:2679—2689.
23.
Cassel S., Revel MO, Kelche C., et al: Expression of the methyl-CpG-binding protein MECP2 in rat brain. An ontogenetic study. Neurobiol Dis2004;15:206—211.
24.
Cohen DR, Matarazzo V., Palmer AM, et al: Expression of MECP2 in olfactory receptor neurons is developmentally regulated and occurs before synaptogenesis. Mol Cell Neurosci2003;22:417—429.
25.
Coy JF, Sedlacek Z., Bachner D., et al: A complex pattern of evolutionary conservation and alternative polyadenylation within the long 3`-untranslated region of the methyl-CpG-binding protein 2 gene (MECP2) suggests a regulatory role in gene expression. Hum Mol Genet1999;8:1253—1262.
26.
Jung BP, Jugloff DG, Zhang G., et al: The expression of methyl CpG binding factor MECP2 correlates with cellular differentiation in the developing rat brain and in cultured cells. J Neurobiol2003;55:86—96.
27.
Kishi N., Macklis JD: MECP2 is progressively expressed in post-migratory neurons and is involved in neuronal maturation rather than cell fate decisions. Mol Cell Neurosci2004;27:306—321.
28.
Mullaney BC , Johnston MV, Blue ME: Developmental expression of methyl-CpG binding protein 2 is dynamically regulated in the rodent brain. Neuroscience2004;123:939—949.
29.
Aber KM, Nori P., MacDonald SM, et al: Methyl-CpG-binding protein 2 is localized in the postsynaptic compartment: an immunochemicalstudyofsubcellularfractions. Neuroscience2003;116:77—80.
30.
Georgel PT, Horowitz-Scherer RA, Adkins N., et al: Chromatin compaction by human MECP2. Assembly of novel secondary chromatin structures in the absence of DNA methylation. J Biol Chem2003;278:32181—32188.
31.
Stancheva I. , Collins AL, Van den Veyver IB, et al: A mutant form of MECP2 protein associated with human Rett syndrome cannot be displaced from methylated DNA by Notch in Xenopus embryos. Mol Cell2003;12:425—435.
Tomita K., Ishibashi M., Nakahara K., et al: Mammalian hairy and Enhancer of split homolog 1 regulates differentiation of retinal neuronsandisessentialforeyemorphogenesis. Neuron1996;16:723—734.
34.
Swiatek PJ, Lindsell CE, del Amo FF, et al: Notch1 is essential for postimplantation development in mice . Genes Dev1994;8:707—719.
35.
Oka C., Nakano T., Wakeham A., et al: Disruption of the mouse RBP-J kappa gene results in early embryonic death. Development1995;121:3291—3301.
36.
Conlon RA, Reaume AG, Rossant J.: Notch1 is required for the coordinate segmentation of somites. Development1995;121:1533—1545.
37.
Zhao X., Ueba T., Christie BR, et al: Mice lacking methyl-CpG binding protein 1 have deficits in adult neurogenesis and hippocampal function. Proc Natl Acad Sci U S A2003;100:6777—6782.
38.
Chen WG, Chang Q., Lin Y., et al: Depression of BDNF transcription involves calcium-dependent phosphorylation of MECP2. Science2003;302:885—889.
39.
Horike S., Cai S., Miyano M., et al: Loss of silent-chromatin looping and impaired imprinting of DLX5 in Rett syndrome. Nat Genet2005;37:31—40.
40.
Martinowich K. , Hattori D., Wu H., et al: DNA-methylation-related chromatin remodeling in activity-dependent BDNF gene regulation. Science2003;302:890—893.
41.
Matarazzo V., Cohen D., Palmer AM, et al: The transcriptional repressor MECP2 regulates terminal neuronal differentiation. Mol Cell Neurosci2004;27:44—58.
42.
Armstrong D., Dunn JK, Antalffy B., et al: Selective dendritic alterations in the cortex of Rett syndrome . J Neuropathol Exp Neurol1995;54:195—201.
43.
Bauman ML, Kemper TL, Arin DM: Pervasive neuroanatomic abnormalities of the brain in three cases of Rett's syndrome. Neurology1995;45:1581—1586.
44.
Bauman ML, Kemper TL, Arin DM: Microscopic observations of the brain in Rett syndrome. Neuropediatrics1995;26:105—108.
45.
Gorski JA, Zeiler SR, Tamowski S., et al: Brain-derived neurotrophic factor is required for the maintenance of cortical dendrites. J Neurosci2003;23:6856—6865.
46.
Xu B., Zang K., Ruff NL, et al: Cortical degeneration in the absence of neurotrophin signaling: Dendritic retraction and neuronal loss after removal of the receptor TrkB . Neuron2000;26:233—245.
47.
Gates MA, Tai CC, Macklis JD: Neocortical neurons lacking the protein-tyrosine kinase B receptor display abnormal differentiation and process elongation in vitro and in vivo. Neuroscience2000;98:437—447.
48.
Egaas B., Courchesne E., Saitoh O.: Reduced size of corpus callosum in autism. Arch Neurol1995;52:794—801.
49.
Gotoh H., Suzuki I., Maruki K., et al: Magnetic resonance imaging and clinical findings examined in adulthood—Studies on three adults with Rett syndrome. Brain Dev2001;23(Suppl1):S118-S121.
50.
Escayg A., MacDonald BT, Meisler MH, et al: Mutations of SCN1A, encoding a neuronal sodium channel, in two families with GEFS+2. Nat Genet2000;24:343—345.
51.
Wallace RH, Wang DW, Singh R., et al: Febrile seizures and generalized epilepsy associated with a mutation in the Na+-channel beta1 subunit gene SCN1B. Nat Genet1998;19:366—370.
52.
Lunyak VV, Burgess R., Prefontaine GG, et al: Corepressordependent silencing of chromosomal regions encoding neuronal genes. Science2002;298:1747—1752.
53.
Planells-Cases R., Caprini M., Zhang J., et al: Neuronal death and perinatal lethality in voltage-gated sodium channel alpha(II)-deficient mice. Biophys J2000;78:2878—2891.
54.
Stuhmer T., Anderson SA, Ekker M., et al: Ectopic expression of the Dlx genes induces glutamic acid decarboxylase and Dlx expression. Development2002;129:245—252.
55.
Amir RE, Van den Veyver IV, Wan M., et al: Rett syndome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nature Genetics1999;23(2):127—128.
56.
Rett A.: Uber ein zerebral-atrophisches Syndrome bei Hyperammonemie. Wien Med Wochenschr1966;116:723—726.
